IP Library Granted Patent US 7,906,325
Granted Patent B2
US 7,906,325 · App. 10/556,950 · Granted Mar 15, 2011

Modification of fatty acid biosynthesis using recombinant diacylglycerol acyltransferase sequences from ryegrass (

Assignees: Agriculture Victoria Services Pty Ltd; AgResearch Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,906,325
App. No.
10/556,950
Granted
Mar 15, 2011
Kind
B2
Abstract

The present invention relates to nucleic acids or nucleic acid fragments encoding amino acid sequences for fatty acid biosynthesis enzymes in plants, and the use thereof for the modification of, for example, fatty acid biosynthesis in plants. In particular, the present invention relates to nucleic acids or nucleic acid fragments encoding amino acid sequences of diacylglycerol acyltransferase enzymes.

Claims (42)

1. A substantially purified or isolated nucleic acid, said nucleic acid consisting of a nucleotide sequence selected from the group consisting of:

(a) SEQ ID No: 10;

(b) SEQ ID No: 38;

(c) a variant of SEQ ID No: 38, wherein the variant is different from SEQ ID NO.: 38 as a consequence of one or more nucleotide changes and wherein all of the changes result in conservative amino acid substitutions, with the proviso that the variant of SEQ ID No 38 has at least 95% sequence identity with SEQ ID No: 38;

(d) the complement of SEQ ID No: 10;

(e) the complement of SEQ ID No: 38;

(f) the complement of the variant as defined in (c); and

(g) a nucleic acid fragment that has a length of at least 60 nucleotides wherein the entire sequence of the nucleic acid fragment is the same as or the complement of a sequence of the same length within SEQ ID No: 10.

2. The nucleic acid of claim 1 , said nucleic acid consisting of a nucleotide sequence selected from the group consisting of:

(a) SEQ ID No: 10;

(b) SEQ ID No: 38;

(c) the complement of SEQ ID No: 10;

(d) the complement of SEQ ID No: 38; and

(e) a nucleic acid fragment that has a length of at least 60 nucleotides wherein the entire sequence of the nucleic acid fragment is the same as or the complement of a sequence of the same length within SEQ ID No: 10.

3. The nucleic acid of claim 1 , said nucleic acid consisting of a nucleotide sequence selected from the group consisting of:

(a) SEQ ID No: 10;

(b) SEQ ID No: 38;

(c) the complement of SEQ ID No: 10;

(d) the complement of SEQ ID No: 38; and

(e) a variant of SEQ ID No: 38, wherein the variant is different from SEQ ID NO.: 38 as a consequence of one or more nucleotide changes and wherein all of the changes result in conservative amino acid substitutions, with the proviso that the variant of SEQ ID No 38 has at least 95% sequence identity with SEQ ID No: 38.

4. A construct including one or more nucleic acids according to claim 1 .

5. A preparation for transforming a plant comprising a nucleic acid according to claim 1 , or a construct according to claim 4 .

6. A substantially purified or isolated nucleic acid, said nucleic acid consisting of a nucleotide sequence selected from the group consisting of:

(a) SEQ ID No: 26;

(b) SEQ ID No: 27;

(c) the complement of SEQ ID No: 26;

(d) the complement of SEQ ID No: 27; and

(e) a nucleic acid fragment that has a length of at least 60 nucleotides wherein the sequence is the same as or the complement of a sequence of the same length within SEQ ID No: 26.

7. A construct including one or more nucleic acids according to claim 6 .

8. A construct according to claim 7 wherein the one or more nucleic acids are operably linked to one or more regulatory elements, such that the one or more nucleic acids are each expressed.

9. A construct according to claim 8 , wherein the one or more regulatory elements include a promoter and a terminator, said promoter, nucleic acid or nucleic acid fragment and terminator being operably linked.

10. A preparation for transforming a plant comprising a nucleic acid according to claim 6 , or a construct according to claim 7 .

11. A substantially purified or isolated nucleic acid, said nucleic acid comprising a nucleotide sequence selected from the group consisting of:

(a) SEQ ID No: 26;

(b) SEQ ID No: 27;

(c) the complement of SEQ ID No: 26; and

(d) the complement of SEQ ID No: 27.

12. A substantially purified or isolated nucleic acid, said nucleic acid comprising a nucleotide sequence selected from the group consisting of:

(a) SEQ ID No: 10;

(b) SEQ ID No: 38;

(c) the complement of SEQ ID No: 10; and

(d) the complement of SEQ ID No: 38.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2021
From: AGRESEARCH LIMITED
To: AGRICULTURE VICTORIA SERVICES PTY LTD
Reel/Frame 056986/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2009
From: BURLING, MARGARET FIONA
To: AGRESEARCH LIMITED
Reel/Frame 022072/0037 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2007
From: BRYAN, GREGORY THOMAS; ROBERTS, NICHOLAS JOHN; WOODFIELD, DEREK ROSS; TROLLOPE, ALANA JEAN
To: AGRICULTURE VICTORIA SERVICES PTY LTD.; AGRESEARCH LIMITED
Reel/Frame 019034/0910 →
Priority Claims (1)
AU 2003902413 · May 16, 2003 · national
Continuity (1)
Related Publication 20070118927A1 · May 24, 2007